Minneapolis, MNNCT06321601Now EnrollingIRB Ready

Granulomatosis with polyangiitis Clinical Trial in Minneapolis, MN

Access cutting-edge granulomatosis with polyangiitis treatment through this clinical trial at a research site in Minneapolis. Study-provided care at no cost to qualified participants.

Sponsored by Amgen

Quick Self-Assessment

See if you qualify for this Minneapolis location

Preparing your pre-screening questions...

Expert Care in Minneapolis

Access granulomatosis with polyangiitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related granulomatosis with polyangiitis treatment provided free

Apply for This Minneapolis Location

Check if you qualify for this granulomatosis with polyangiitis clinical trial in Minneapolis, MN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Minneapolis

    Convenient for MN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Minneapolis site if eligible
  4. 4Begin participation

About This Granulomatosis with polyangiitis Study in Minneapolis

The main objective of this study is to explore the efficacy of avacopan in participants affected by AAV.

Sponsor: Amgen

Who Can Participate

Inclusion Criteria

Male and female children and adolescents from 6 to \< 18 years of age
Clinical diagnosis of granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), consistent with Chapel-Hill Consensus Conference definitions (Jennette et al, 2013)
Newly diagnosed or relapsed AAV with positive test for anti-PR3 or anti-MPO antibodies
At least 1 PVAS major item, at least 3 PVAS nonmajor items, or at least the 2 renal items of proteinuria and hematuria.
eGFR \> 15 mL/min/1.73 m2 (using modified Schwartz equation per central lab guidelines)
Participants must have a bodyweight of ≥ 15 kg at day 1.

Exclusion Criteria

Any other known multisystem autoimmune disease including eosinophilic granulomatosis with polyangiitis (Churg-Strauss), systemic lupus erythematosus , IgA vasculitis (Henoch-Schönlein), rheumatoid vasculitis, Sjogren's syndrome, anti-glomerular basement membrane disease, or cryoglobulinemic vasculitis
Alveolar hemorrhage requiring invasi

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Minneapolis?

Yes, this clinical trial (NCT06321601) has an active research site in Minneapolis, MN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Granulomatosis with polyangiitis Treatment Options in Minneapolis, MN

If you're searching for granulomatosis with polyangiitis treatment options in Minneapolis, MN, this clinical trial (NCT06321601) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Minneapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced granulomatosis with polyangiitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all granulomatosis with polyangiitis clinical trials near you to find additional studies recruiting in your area.

More Rheumatoid Arthritis Trials in Minneapolis, MN

See all rheumatoid arthritis clinical trials recruiting in Minneapolis — not just this study.

Browse Rheumatoid Arthritis Trials in Minneapolis →

Browse More Trials by Condition

Rheumatoid Arthritis TrialsVasculitis TrialsAll Conditions →

Ready to Join in Minneapolis?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Minneapolis, MN